If insulin resistance develops, the effectiveness of insulin decreases; [6, 7] insulin resistance (IR) is a dynamic pathological disorder resulting from inadequate cellular response to insulin [8, 9] in insulin-dependent cells, which occurs in various metabolic disorders, including type 2 diabetes (T2D) and metabolic syndrome [10, 11]. This evidence concerns the gene INS and metabolic disease.